GlassScriptPhysician profile
Michael Scott Vrana
NPI 1164602868
$9,231.87
in general payments reported to CMS, 2019-2025
12 companies · $2,049 in 2025
The $2,049 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2021: $72.83 · 2022: $2,439 · 2023: $2,336 · 2024: $1,890 · 2025: $2,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,242 · Food and Beverage: $2,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,242.00 |
| Food and Beverage | $2,033.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,256.60 | 2022-2025 | Journey, Ri Hip Navigation, Or3o Dual Mobility |
| Esaote North America, INC. | $294.00 | 2019 | |
| Medtronic, INC. | $215.35 | 2022-2024 | Kyphon Express II Kyphopak Tray |
| Pacira Pharmaceuticals Incorporated | $189.49 | 2019-2025 | Exparel, Zilretta, Iovera |
| Stryker Corporation | $78.84 | 2021-2025 | Pangea |
| Spr Therapeutics, INC | $77.50 | 2024 | Sprint Pns System |
| Anika Therapeutics, INC. | $32.06 | 2023 | Revomotion |
| Abbott Laboratories | $24.36 | 2023 | Proclaim |
| Bioventus LLC | $18.55 | 2025 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $16.13 | 2024 | Truespan Orthocord |
| Ethicon US, LLC | $16.11 | 2021 | |
| Pacira Therapeutics, INC. | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Vrana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.